(Q45120061)

English

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

scientific article published in October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

medulloblastoma

0 references

adaptive radiation therapy

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

11

object named as

Maryam Fouladi

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

Amar Gajjar

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Murali Chintagumpala

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

David Ashley

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Stewart Kellie

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Larry E Kun

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Thomas E Merchant

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Shaio Woo

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Greg Wheeler

8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Valerie Ahern

9

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Matthew J Krasin

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Alberto Broniscer

12

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Robert Krance

13

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Gregory A Hale

14

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Clinton F Stewart

15

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Robert Dauser

16

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Robert A Sanford

17

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Christine Fuller

18

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Ching Lau

19

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

James M Boyett

20

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dana Wallace

21

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Richard J Gilbertson

22

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

813-820

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Current therapy for medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose escalation trial of cyclophosphamide with Sargramostim in the treatment of central nervous system (CNS) neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose: a critical factor in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Medulloblastoma: signalling a change in treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Late neurocognitive sequelae in survivors of brain tumours in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970867-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(06)70867-1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45120061&oldid=2066427007"